
Sign up to save your podcasts
Or
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
4.2
229229 ratings
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
3,878 Listeners
37,835 Listeners
3,895 Listeners
32,118 Listeners
43,471 Listeners
6,711 Listeners
25,810 Listeners
10,662 Listeners
58 Listeners
110,870 Listeners
2,256 Listeners
29 Listeners
6,944 Listeners
16,045 Listeners
3 Listeners
0 Listeners
5 Listeners
15,512 Listeners
34 Listeners
1,488 Listeners